1.
Impact of CYP3A4 and CYP3A5 Genetic Variants on Tacrolimus Dosing and Therapeutic Outcomes in Kidney Transplant Recipients. Majalah Kedokteran Bandung [Internet]. 2026 Jun. 30 [cited 2026 Jul. 23];58(2):123-31. Available from: https://journal.fk.unpad.ac.id/index.php/mkb/article/view/4879